These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


356 related items for PubMed ID: 16822701

  • 41. In silico pharmacology for a multidisciplinary drug discovery process.
    Ortega SS, Cara LC, Salvador MK.
    Drug Metabol Drug Interact; 2012; 27(4):199-207. PubMed ID: 23152402
    [Abstract] [Full Text] [Related]

  • 42. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF, Asatryan H, Li J, Zhou Y.
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [Abstract] [Full Text] [Related]

  • 43. Drug discovery, drug development and the emerging world of pharmacogenomics: prospecting for information in a data-rich landscape.
    Michelson S, Joho K.
    Curr Opin Mol Ther; 2000 Dec; 2(6):651-4. PubMed ID: 11249742
    [Abstract] [Full Text] [Related]

  • 44. Structure-guided fragment screening for lead discovery.
    Verdonk ML, Hartshorn MJ.
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
    [Abstract] [Full Text] [Related]

  • 45. Discovery of a new drug--from target identification to ultra-high-throughput screening.
    Golz S, Hüser J.
    Clin Lab; 2007 Jul; 53(1-2):77-9. PubMed ID: 17323829
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S, Aharon A, Ben-Moshe T, Marantz Y, Senderowitz H.
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM, Simms B, Nigsch F, Lounkine E, Kutchukian P, Cornett A, Deng Z, Davies JW, Jenkins JL, Glick M.
    ACS Chem Biol; 2012 Aug 17; 7(8):1399-409. PubMed ID: 22594495
    [Abstract] [Full Text] [Related]

  • 50. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V, Zimmermann M, Maass A, Schwichtenberg H, Wolf A, Jacq N, Breton V, Hofmann-Apitius M.
    J Chem Inf Model; 2007 Aug 17; 47(5):1818-28. PubMed ID: 17727268
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.
    Crisman TJ, Jenkins JL, Parker CN, Hill WA, Bender A, Deng Z, Nettles JH, Davies JW, Glick M.
    J Biomol Screen; 2007 Apr 17; 12(3):320-7. PubMed ID: 17438067
    [Abstract] [Full Text] [Related]

  • 57. New screening tools for lead compound identification.
    Sawyer TK.
    Nat Chem Biol; 2005 Aug 17; 1(3):125. PubMed ID: 16408012
    [No Abstract] [Full Text] [Related]

  • 58. Snapshot PK: a rapid rodent in vivo preclinical screening approach.
    Liu B, Chang J, Gordon WP, Isbell J, Zhou Y, Tuntland T.
    Drug Discov Today; 2008 Apr 17; 13(7-8):360-7. PubMed ID: 18405850
    [Abstract] [Full Text] [Related]

  • 59. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T.
    Curr Opin Drug Discov Devel; 2005 Jul 17; 8(4):513-9. PubMed ID: 16022188
    [Abstract] [Full Text] [Related]

  • 60. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D, Fogel GB.
    J Chem Inf Model; 2009 Apr 17; 49(4):1105-21. PubMed ID: 19348414
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.